8.77
price up icon1.68%   0.145
 
loading
前日終値:
$8.625
開ける:
$8.84
24時間の取引高:
130.30K
Relative Volume:
1.96
時価総額:
$746.28M
収益:
$213.45M
当期純損益:
$-72.46M
株価収益率:
-8.8265
EPS:
-0.9936
ネットキャッシュフロー:
$-47.28M
1週間 パフォーマンス:
+0.23%
1か月 パフォーマンス:
+21.50%
6か月 パフォーマンス:
+28.59%
1年 パフォーマンス:
+20.63%
1日の値動き範囲:
Value
$8.77
$9.11
1週間の範囲:
Value
$8.0528
$9.11
52週間の値動き範囲:
Value
$3.62
$12.25

Valneva Se Adr Stock (VALN) Company Profile

Name
名前
Valneva Se Adr
Name
セクター
Healthcare (1150)
Name
電話
-
Name
住所
-
Name
職員
713
Name
Twitter
Name
次回の収益日
2025-03-21
Name
最新のSEC提出書
Name
VALN's Discussions on Twitter

VALN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VALN
Valneva Se Adr
8.77 752.53M 213.45M -72.46M -47.28M -0.9936
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.62 100.25B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.80 61.55B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.23 58.53B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
722.01 43.59B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.26 33.67B 3.81B -644.79M -669.77M -6.24

Valneva Se Adr Stock (VALN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-19 再開されました H.C. Wainwright Buy
2022-08-03 開始されました H.C. Wainwright Buy

Valneva Se Adr (VALN) 最新ニュース

pulisher
Aug 28, 2025

Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ - MSN

Aug 28, 2025
pulisher
Aug 27, 2025

Valneva selloff on FDA suspension overdone, says H.C. Wainwright - MSN

Aug 27, 2025
pulisher
Aug 27, 2025

Valneva SE ADR: Rising -26.86% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

Aug 27, 2025
pulisher
Aug 26, 2025

Valneva price target lowered to $14 from $18 at Jefferies - MSN

Aug 26, 2025
pulisher
Aug 25, 2025

Jefferies lowers Valneva stock price target to $14 on FDA suspension - Investing.com

Aug 25, 2025
pulisher
Aug 25, 2025

Valneva stock tumbles as FDA suspends license for IXCHIQ vaccine By Investing.com - Investing.com South Africa

Aug 25, 2025
pulisher
Aug 25, 2025

Valneva stock tumbles as FDA suspends license for IXCHIQ vaccine - Investing.com

Aug 25, 2025
pulisher
Aug 25, 2025

Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S. - GlobeNewswire Inc.

Aug 25, 2025
pulisher
Aug 24, 2025

Valneva (NASDAQ:VALN) Shares Gap Up – Still a Buy? - Defense World

Aug 24, 2025
pulisher
Aug 22, 2025

HC Wainwright Estimates Valneva’s Q3 Earnings (NASDAQ:VALN) - Defense World

Aug 22, 2025
pulisher
Aug 20, 2025

Valneva (NASDAQ:VALN) Coverage Initiated by Analysts at HC Wainwright - Defense World

Aug 20, 2025
pulisher
Aug 18, 2025

Short Interest in Valneva SE Sponsored ADR (NASDAQ:VALN) Expands By 91.2% - Defense World

Aug 18, 2025
pulisher
Aug 15, 2025

Valneva (NASDAQ:VALN) Trading Up 14.3% After Better-Than-Expected Earnings - Defense World

Aug 15, 2025
pulisher
Aug 13, 2025

Valneva (NASDAQ:VALN) Shares Gap Up Following Better-Than-Expected Earnings - Defense World

Aug 13, 2025
pulisher
Aug 13, 2025

Valneva SE earnings beat by $0.22, revenue topped estimates - Investing.com

Aug 13, 2025
pulisher
Aug 12, 2025

Valneva (NASDAQ:VALN) Trading Down 6.7% – Here’s What Happened - Defense World

Aug 12, 2025
pulisher
Aug 10, 2025

Valneva (NASDAQ:VALN) Sets New 1-Year High – Still a Buy? - Defense World

Aug 10, 2025
pulisher
Aug 08, 2025

European ADRs Tick Up As Healthcare And Industrials Shine - Finimize

Aug 08, 2025
pulisher
Jul 24, 2025

Valneva (VALN) Soars 17.4%: Is Further Upside Left in the Stock? - Yahoo Finance

Jul 24, 2025
pulisher
Jun 05, 2025

[Valneva SE] Declaration of shares and voting rights - GlobeNewswire Inc.

Jun 05, 2025
pulisher
May 07, 2025

Valneva SE earnings missed by $0.01, revenue topped estimates - Investing.com

May 07, 2025
pulisher
May 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - Louisiana First News

May 06, 2025
pulisher
Apr 30, 2025

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Louisiana First News

Apr 30, 2025
pulisher
Apr 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - GlobeNewswire Inc.

Apr 25, 2025
pulisher
Apr 22, 2025

Valneva SE Company Investigated by the Portnoy Law Firm - GlobeNewswire

Apr 22, 2025
pulisher
Apr 15, 2025

Valneva shares leap on Brazilian approval of chikungunya vaccine By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 14, 2025

Valneva shares leap on Brazilian approval of chikungunya vaccine - Investing.com Australia

Apr 14, 2025
pulisher
Apr 10, 2025

VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study - MSN

Apr 10, 2025
pulisher
Apr 10, 2025

VALN Doses First Infant With Shigella Vaccine In Mid-Stage Study - Barchart.com

Apr 10, 2025
pulisher
Apr 10, 2025

H.C. Wainwright maintains Buy on Valneva with $17 price target - Investing.com

Apr 10, 2025
pulisher
Apr 09, 2025

Valneva SE ADR’s Banking’s 100-Day Moving Average at 5.61: Will the Stock Break Through? - investchronicle.com

Apr 09, 2025
pulisher
Apr 07, 2025

The Schall Law Probes Valneva Over Vaccine Safety Concerns - Lawyer Monthly

Apr 07, 2025
pulisher
Apr 04, 2025

VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm - Business Wire

Apr 04, 2025

Valneva Se Adr (VALN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$86.96
price up icon 1.14%
$27.08
price up icon 4.60%
$23.52
price down icon 1.34%
$100.42
price down icon 0.20%
$143.50
price down icon 1.24%
biotechnology ONC
$336.26
price up icon 1.27%
大文字化:     |  ボリューム (24 時間):